Open AccessRemifentanil in labor
Author(s) -
Basavana Gouda Goudra,
Preet Mohinder Singh
Publication year - 2013
Publication title -
journal of obstetric anaesthesia and critical care/journal of obstetric anaesthesia and critial care
Language(s) - English
Resource type - Journals
eISSN - 2249-9539
pISSN - 2249-4472
DOI - 10.4103/2249-4472.123298
Subject(s) - remifentanil , medicine , popularity , therapeutic window , depression (economics) , intensive care medicine , suite , window (computing) , anesthesia , pharmacology , psychology , law , economics , computer science , social psychology , world wide web , political science , propofol , macroeconomics
Remifentanil is in clinical use for over 15 years. In spite of its unparalleled popularity, largely due to its unique pharmacokinetics, its place in labor analgesia is yet to be determined. Narrow therapeutic window and ability to cause rapid and severe respiratory depression are some of the major setbacks. Need for close monitoring, at least in the initial implementation stage is mandatory. Education of the labor suite nurses along with innovative monitoring technique is needed to realize the full potential of remifentanil in the labor room